EUESMA 2023 Survey Results
We’re thrilled to share the latest publication in SMA Europe’s One Goal editorial series!
SMA Newsroom
Nov 17, 2025
Community Update on the positive decision by EMA regarding the high-dose regimen of nusinersen in the treatment of SMA.
Biogen announced that the high dose regimen of nusinersen received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
“SMA Europe online tool helps patients find clinical trials” published by SMA News Today
We are delighted to invite you to read the latest article on our Clinical Trials Finder website by SMA News Today.
Sep 30, 2025
“SMA Europe Launched New Clinical Trials Finder to Support Access to Clinical Trials and Accelerate Progress in SMA Treatment” published by Rare Revolution Magazine.
We are delighted to invite you to read the latest article on our Clinical Trials Finder website by Rare Revolution Magazine.